OSCR
Oscar Health, Inc.
+0.82 (+2.54%)33.16USD2.4M成交股數11.1B市值22.9本益比(近四季)373.8股價營收比-6.2%營收年增(近四季)2026-11-09下次財報
財報 SEC XBRL 申報值 · 美元 · 財年於 12 月結束
逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。
營收與利潤率近 16 季
稀釋 EPS近 16 季 · 美元
現金流近 16 季
股東回饋近 16 季 · 庫藏股與股利
損益表 逐季 · 最新在左 · 小字是年增率
| 科目 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q3 | 23Q2 | 23Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營收 | 6.1M+41% | 5.7M+19% | 8.8M+80% | 6.5M+24% | 4.3M-23% | 4.8M-13% | 4.9M-4% | 5.2M+5% | 5.6M | 5.5M | 5.1M | 5.0M |
| 營業成本 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 研發費用 | – | – | – | – | – | – | – | – | – | – | – | – |
| 銷售管理費用 | 691M | 706M | 522M | 534M | 483M | 466M | 460M | 435M | 394M | 326M | 337M | 399M |
| 營業利益 | 389M+31% | 704M-577% | −129M+167% | −230M-440% | 297M+60% | −148M+154% | −48.4M+641% | 67.8M-367% | 186M | −58.2M | −6.5M | −25.4M |
| 營業利益率 | 6,376.3% | 12,313.5% | -1,468.6% | -3,547.5% | 6,862.0% | -3,070.1% | -987.4% | 1,296.3% | 3,293.5% | -1,051.1% | -128.4% | -507.0% |
| 稅後淨利 | 362M+31% | 679M-542% | −137M+152% | −228M-506% | 275M+55% | −154M+135% | −54.6M+252% | 56.2M-241% | 177M | −65.4M | −15.5M | −39.8M |
| 淨利率 | 5,936.1% | 11,874.7% | -1,561.8% | -3,514.9% | 6,357.3% | -3,190.9% | -1,114.4% | 1,074.5% | 3,148.2% | -1,180.3% | -305.4% | -795.0% |
| 稀釋 EPS | 1.10+20% | 2.07-514% | -0.53+141% | -0.89-545% | 0.92+48% | -0.50+72% | -0.22+214% | 0.20-211% | 0.62 | -0.29 | -0.07 | -0.18 |
| 稀釋股數 | 333M | 330M | 259M | 256M | 306M | 266M | 243M | 304M | 294M | 223M | 219M | 217M |
資產負債表 期末餘額
| 科目 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q3 | 23Q2 | 23Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 現金與約當現金 | 4.1B | 4.8B | 2.1B | 2.6B | 2.2B | 1.5B | 1.2B | 2.3B | 2.2B | 1.4B | 2.3B | 2.1B |
| 應收帳款 | 380M | 587M | – | – | – | – | – | – | – | – | – | – |
| 存貨 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總資產 | 11.2B | 9.3B | 5.7B | 6.4B | 5.8B | 4.8B | 4.5B | 5.0B | 4.4B | 3.3B | 4.6B | 4.5B |
| 有息負債 | 432M | 431M | 686M | 300M | 300M | 300M | 299M | 299M | 299M | 299M | 298M | 298M |
| 總負債 | 9.2B | 7.6B | 4.7B | 5.2B | 4.5B | 3.8B | 3.3B | 3.9B | 3.4B | 2.4B | 3.6B | 3.6B |
| 股東權益 | 2.1B | 1.7B | 1.0B | 1.2B | 1.3B | 1.0B | 1.2B | 1.1B | 1.0B | 919M | 950M | 930M |
| 負債比 | 81.7% | 82.1% | 82.1% | 81.8% | 77.1% | 79.0% | 74.0% | 77.2% | 76.6% | 72.5% | 79.1% | 79.2% |
| 淨現金(現金 − 有息負債) | 3.6B | 4.4B | 1.5B | 2.3B | 1.9B | 1.2B | 907M | 2.0B | 1.9B | 1.1B | 2.0B | 1.8B |
現金流量表 單季
| 科目 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q3 | 23Q2 | 23Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營業現金流 | – | 2.6B | – | – | 879M+38% | – | – | – | 634M | – | – | 415M |
| 資本支出 | – | 8.8M | – | – | 9.0M | – | – | – | 6.0M | – | – | 7.4M |
| 自由現金流 | – | 2.6B | – | – | 870M+38% | – | – | – | 628M | – | – | 407M |
| 折舊攤銷 | – | 7.0M | – | – | 6.7M | – | – | – | 7.8M | – | – | 4.9M |
| 買回庫藏股 | – | – | – | – | – | – | – | – | – | – | – | – |
| 現金股利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流率 | – | 45,648.6% | – | – | 20,081.2% | – | – | – | 11,153.9% | – | – | 8,141.8% |
營收拆解
這家公司的 XBRL 沒有標分部、產品或地區營收。多半是單一業務,或只在 10-K 文字裡揭露。
各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。
年度 10-K
| 財年 | 營收 | 年增 | 稅後淨利 | 淨利率 | 稀釋 EPS | 自由現金流 |
|---|---|---|---|---|---|---|
| FY2025 | 28.6M | +39.0% | −443M | -1,549.9% | -1.69 | 1.1B |
| FY2024 | 20.6M | -3.6% | 25.4M | 123.6% | 0.10 | 950M |
| FY2023 | 21.4M | -67.1% | −271M | -1,267.9% | -1.22 | −298M |
| FY2022 | 64.9M | +1103.7% | −606M | -933.8% | -2.85 | 351M |
| FY2021 | 5.4M | – | −573M | -10,615.6% | -3.20 | −208M |
| FY2020 | 0.00 | -100.0% | −407M | –% | -14.16 | 209M |
| FY2019 | 488M | – | −261M | -53.5% | -9.06 | −191M |